Trial
NCT03313414
HCV Post-Exposure Prophylaxis for Health Care Workers
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Massachusetts General Hospital
Collaborators
Gilead Sciences
Condition
Hepatitis C
Intervention
Sofosbuvir/Velpatasvir Treatment for 14 days
Why stopped
No participant enrollment, funding withdrawn.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-21